Efficacy of Intralesional Measles Mumps Rubella Vaccine in the Treatment of Verruca Vulgaris: An Interventional Study. [PDF]
Surani AS, Un R, Marfatia Y.
europepmc +1 more source
Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. [PDF]
Krow-Lucal E +5 more
europepmc +1 more source
A phase II/III randomised, comparative study evaluating the safety and immunogenicity of Biological E's live, attenuated Measles-Rubella vaccine in 9-12 month old healthy infants. [PDF]
Thuluva S +7 more
europepmc +1 more source
Intralesional Measles-Mumps-Rubella Vaccine for Genital Warts: Report of two cases with a review of literature. [PDF]
Al-Qassabi AM, Al-Farsi F.
europepmc +1 more source
Immunogenicity of measles-rubella vaccine administered under India's Universal Immunization Programme in the context of measles-rubella elimination goal: A longitudinal study. [PDF]
Verma SK +5 more
europepmc +1 more source
Buschke-Lowenstein tumor treated with intralesional measles, mumps, and rubella vaccine. [PDF]
Deshmukh A +3 more
europepmc +1 more source
Sex-based differences in mumps immunity after a third dose of measles-mumps-rubella vaccine. [PDF]
Quach HQ +5 more
europepmc +1 more source
Mumps vaccine effectiveness of a 3rd dose of measles, mumps, rubella vaccine in school settings during a mumps outbreak -- Arkansas, 2016-2017. [PDF]
Guo A +10 more
europepmc +1 more source
Safety and Tolerance of a Novel MMR (Measles, Mumps, and Rubella) Vaccine in Indian Children: A Real-World Evidence Study. [PDF]
Pula JR +10 more
europepmc +1 more source

